For: | Broquetas T, Carrión JA. Past, present, and future of long-term treatment for hepatitis B virus. World J Gastroenterol 2023; 29(25): 3964-3983 [PMID: 37476586 DOI: 10.3748/wjg.v29.i25.3964] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i25/3964.htm |
Number | Citing Articles |
1 |
Xiaohui Fang, Yuhang Yin, Haonan Zhao, Cai’e Wang, Hui Li, Yiyang Shang, Jiayu Li, Yue Gao, Nahum Méndez-Sánchez, Xingshun Qi. Effect of fatty liver disease on liver function and fibrosis in patients with chronic hepatitis B: a cross-sectional study. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1481051
|
2 |
Valeria Reynolds-Cortez, Juan-José Criado-Álvarez, Vicente Martinez-Vizcaino, Carlos Pascual-Morena, Ana Salinas-Vilca, Irene Sequí-Domínguez. The Effectiveness and Sero-Immunity of Hepatitis B Vaccination in People Who Use Drugs: A Systematic Review and Meta-Analysis. Vaccines 2024; 12(9): 1026 doi: 10.3390/vaccines12091026
|
3 |
Jianpeng Wang, Xinyi Wang, Enba Zhuo, Bangjie Chen, Shixin Chan. Gut‑liver axis in liver disease: From basic science to clinical treatment (Review). Molecular Medicine Reports 2024; 31(1) doi: 10.3892/mmr.2024.13375
|
4 |
Zi-Hong Bao, Zhi-Kun Dai, Hao-Xian Tang. Antiviral treatment standards for hepatitis B: An urgent need for expansion. World Journal of Gastroenterology 2024; 30(4): 418-420 doi: 10.3748/wjg.v30.i4.418
Abstract(351) |
Core Tip(361) |
Full Article(HTML)(950)
|
Full Article with Cover (PDF)-770K(59)
|
Full Article (Word)-104K(14)
|
Audio-627K(8)
|
Peer-Review Report-197K(42)
|
Answering Reviewers-80K(49)
|
Full Article (PDF)-336K(91)
|
Full Article (XML)-30K(36)
|
Times Cited (1)
|
Total Visits (2704)
|
Open
|
5 |
Yiqi Xiong, Wenying Qiao, Qi Wang, Kang Li, Ronghua Jin, Yonghong Zhang. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1357496
|
6 |
Samuel W. Gillespie, Athreya S. Reddy, Dana M. Burris, S. Hasan Naqvi, Siddappa N. Byrareddy, Christian L. Lorson, Kamal Singh. Islatravir: evaluation of clinical development for HIV and HBV. Expert Opinion on Investigational Drugs 2024; 33(2): 85 doi: 10.1080/13543784.2024.2305130
|
7 |
Fabiola Di Dato, Raffaele Iorio. Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone?. World Journal of Gastroenterology 2024; 30(17): 2294-2297 doi: 10.3748/wjg.v30.i17.2294
|